Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
4DMedical Ltd ( (AU:4DX) ) just unveiled an update.
4DMedical Ltd has announced the expiry of 636,576 unexercised options (ASX code 4DXAT) with an exercise price of $0.79, which ceased on 17 January 2026. The lapse of these options, which did not convert into ordinary shares, results in a modest simplification of the company’s capital structure and removes a potential source of future equity dilution for existing shareholders.
The most recent analyst rating on (AU:4DX) stock is a Hold with a A$4.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd, listed on the ASX under the code 4DX, is an Australian medical technology company focused on advanced respiratory imaging and analysis solutions for the healthcare sector.
Average Trading Volume: 5,078,969
Technical Sentiment Signal: Buy
Current Market Cap: A$2.61B
Find detailed analytics on 4DX stock on TipRanks’ Stock Analysis page.